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Abstract
Background: A hallmark of chronic liver disease is the impairment of the liver’s innate regenerative ability. In this
work we use a computational approach to unravel the principles underlying control of liver repair following an
acute physiological challenge.
Methods: We used a mathematical model of inter- and intra-cellular interactions during liver regeneration to infer
key molecular factors underlying the dysregulation of multiple regeneration modes, including delayed, suppressed,
and enhanced regeneration. We used model analysis techniques to identify organizational principles governing the
cellular regulation of liver regeneration. We fit our model to several published data sets of deficient regeneration in
rats and healthy regeneration in humans, rats, and mice to predict differences in molecular regulation in disease
states and across species.
Results: Analysis of the computational model pointed to an important balance involving inflammatory signals and
growth factors, largely produced by Kupffer cells and hepatic stellate cells, respectively. Our model analysis results also
indicated an organizational principle of molecular regulation whereby production rate of molecules acted to induce
coarse-grained control of signaling levels while degradation rate acted to induce fine-tuning control. We used this
computational framework to investigate hypotheses concerning molecular regulation of regeneration across species
and in several chronic disease states in rats, including fructose-induced steatohepatitis, alcoholic steatohepatitis,
toxin-induced cirrhosis, and toxin-induced diabetes. Our results indicate that altered non-parenchymal cell activation is
sufficient to explain deficient regeneration caused by multiple disease states. We also investigated liver regeneration
across mammalian species. Our results suggest that non-invasive measures of liver regeneration taken at 30 days
following resection could differentiate between several hypotheses about how human liver regeneration differs from
rat regeneration.
Conclusions: Overall, our results provide a new computational platform integrating a wide range of experimental
information, with broader utility in exploring the dynamic patterns of liver regeneration across species and over
multiple chronic diseases.
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Background
The liver’s unique ability to regenerate allows partial
liver resection to be a viable treatment option for pa-
tients with various liver diseases. Because the liver can
regenerate even when most of its mass is lost (up to
~75 %), typical treatment for hepatocellular carcinoma
involves resection of liver mass containing tumors. Pa-
tients with liver diseases such as cirrhosis can be treated
similarly using partial liver transplant from a live donor,
followed by liver regeneration in both donor and recipi-
ent. Regenerative ability is not equal in all livers, how-
ever. Surgeons have long been wary of transplanting
fatty livers from organ donors because fatty livers regen-
erate insufficiently or not at all [1]. Age, diet, and
miRNA regulation have also been linked to the liver’s
overall regeneration ability [2–6]. Additionally, many
chronic diseases impair liver regeneration and repair fol-
lowing hepatic resection [7]. It has even been postulated
that inhibition of the liver’s natural repair ability
contributes to the progress of steatohepatitis to cirrhosis
in the liver [8].
The mechanisms governing liver regeneration have
been studied extensively over the last several decades
(Fig. 1a) [9–11]. In summary, following partial hepatec-
tomy (PHx), hepatocytes respond within 30 s of tissue
damage. This early hepatocyte response consists of mul-
tiple signals, including release of ATP, increases in WNT
signaling, and ionic calcium release from hepatocytes.
These responses in hepatocytes are likely driven by ex-
trinsic factors including an increase in portal blood flow,
an increase in portal pressure, an increase in metabolic
demand per cell (increased nutrient availability, in-
creased toxin flux, and increased extra-hepatic signals
including LPS), and signaling from factors liberated from
the extracellular matrix coupled with intrinsic factors in-
cluding hepatocyte metabolic capacity, functional his-
tory, and transcriptional state. Signals from the blood
and from hepatocytes activate non-parenchymal cells to
Fig. 1 Schematic representation of the changes occurring during liver regeneration following PHx. a Detailed schematic. (1) Following PHx,
hepatocytes respond within 30 s of tissue damage. Early post-PHx, previous work has shown release of ATP, increases in WNT signaling, and ionic
Calcium release from hepatocyte mitochondria. (2) These responses in hepatocytes are likely to be driven by an increase portal blood flow, an
increase in portal pressure, and an increase in metabolic demand per cell (increased nutrient availability, increased toxin flux, and increased
extra-hepatic signals including LPS). (3) Signals from the blood and from hepatocytes activate non-parenchymal cells to produce factors governing
hepatocyte entry into the cell cycle (including priming). b Simplified schematic diagram. This schematic shows the relationships included in the
computational model. Several important pathways are lumped or represented as physiological transitions rather than including truly mechanistic detail.
This physiological approach allows for insight into control principles of regeneration governed by archetypal signaling pathways. The gray matrix-bound
factor (MBF) signaling was added to the model to investigate the contribution to liver mass recovery of matrix-bound signaling, but because
of a relatively small impact on the dynamic mass recovery was excluded from further analyses
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produce factors governing hepatocyte entry into the cell
cycle. Kupffer cells respond within the first hour post-
PHx to produce cytokines and chemokines that signal to
hepatocytes through the JAK-STAT3 and NF-κB path-
ways and prime hepatocytes for replication. These cyto-
kine signals, coupled with hepatocyte and blood signals,
also activate hepatic stellate cells and endothelial cells
to produce growth factors directly, through de novo
synthesis, and indirectly, through matrix remodeling
and release of matrix-bound growth factors. These
growth factors induce hepatocytes to enter the cell
cycle. While liver mass is still low, non-parenchymal
cells maintain high growth factor bioavailability, which
maintains hepatocytes in the cell cycle as liver mass
regenerates. Following recovery of liver mass, the ter-
mination stage of regeneration begins. During the
termination stage, hepatocytes exit the cell cycle and
re-enter the G0 phase. This requiescence is thought to
be governed by a combination of accumulation of
extracellular matrix, requiescence of non-parenchymal
cells, and an alteration of hepatocyte transcriptional
programs, for example the renormalization of the C/
EBP-α and C/EBP-β switch [12].
Despite clinical relevance and advances in our under-
standing of the molecular mechanisms underlying regen-
eration, however, the organizational principles governing
molecular regulation of liver regeneration remain un-
clear. To investigate these organizational principles, a
computational model of liver regeneration was devel-
oped recently, taking into account growth factor (GF)
signaling, cytokine signaling along the JAK-STAT path-
way, and hepatocyte replication [13]. Furchtgott, Chow,
and Periwal employed this computational model to ac-
count for differential regeneration profiles after various
degrees of partial hepatectomy. This model considered
cell proliferation but not cell growth, thus limiting its
ability to account for liver repair scenarios that involve
hypertrophy in addition to hyperplasia.
In this study, we address this issue by extending the
cell phenotype based computational model of liver re-
generation to include both cell growth and replication
(represented schematically in Fig. 1b). We employ this
extended model to investigate quantitatively how alter-
ing the molecular regulation of hepatocytes affects the
liver’s innate repair ability. Our extended model main-
tains the structure of the original model by combining
classes of molecular signals with physiological observa-
tions of regeneration to capture dynamic regeneration
phenotypes. The parameters and variables included in
our model as well as their approximate biological corre-
lates are provided in Table 1. Briefly, in our model, hepa-
tocytes can exist in one of three states: Quiescent (Q),
Primed (P), or Replicating (R). An increased metabolic
load (metabolic demand per cell or M/N) induced by
partial hepatectomy serves as the initial signal inducing
regeneration in the model (Additional file 1: Figure S1).
Our model uses a lumped approach to modeling these
initiating signals by combining both extrinsic and intrin-
sic factors into the metabolic demand parameter. This
increased metabolic load is modeled as directly activat-
ing non-parenchymal cells, specifically Kupffer cells
(KC) and hepatic stellate cells (HSC), although this acti-
vation likely also involves signals from hepatocytes.
Inflammatory cytokines produced predominantly by
Kupffer cells (represented in the model by IL-6) signal
through the JAK-STAT signaling pathway in hepatocytes
to induce production of immediate early (IE) genes,
which induce hepatocytes to enter the Primed state.
Primed hepatocytes are able to respond to GF signaling
from hepatic stellate cells and enter the Replicating state.
Once in the Replicating state, hepatocytes maintain rep-
lication until natural requiescence or buildup of extracel-
lular matrix (ECM) induces them back to the Quiescent
state. The main benefit provided by our extended model
is that hepatocytes that respond to the increased meta-
bolic load (P and R) can increase their mass to meet
metabolic load as well as enter replication. This corre-
sponds to the biological scenarios of a cell increasing its
mass prior to replication or becoming larger to meet a
functional demand.
Additionally, we extended the model further to consider
explicitly the contributions of initially matrix-bound fac-
tors, MBFs, (including growth factors and potentially
WNT precursors), that are liberated from the matrix dur-
ing remodeling post-PHx. These factors likely contribute
to the quiescent-to-primed transition that hepatocytes
undergo during the priming phase and may be equally as
important as the early, predominantly Kupffer cell-
produced cytokine microenvironment in priming hepato-
cytes for entry to the cell cycle (Fig. 1b, gray portion).
Our extended computational model allowed us to in-
vestigate several issues outstanding in the field of liver
regeneration. We analyzed the extended model to deter-
mine the relative contributions of the predominantly
Kupffer cell-produced cytokine microenvironment and
the ECM-liberated signals to prime hepatocytes to enter
the cell cycle. We simulated the extended model over a
wide range of parameter values and identified parameter
sets giving rise to distinct modes of liver regeneration
and common or unique molecular regulation of liver
regeneration dynamics. We next questioned what
organizational principles regulate the biology of liver re-
generation. Our model-based analyses revealed how al-
tering regulatory balances can shift the liver into
distinct, clinically relevant regeneration modes. We ana-
lyzed multiple published regeneration profiles to identify
common organizational principles underlying liver re-
generation across distinct tissue response phenotypes.
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We then predicted which molecular signaling dysregula-
tion may account for altered liver regeneration profiles in
multiple species and disease scenarios. We also used our
model to compare several hypotheses about differences in
regeneration between humans and rats, and suggest mea-
surements that can be used to test these hypotheses. We
hope that understanding how organizational principles
work together to govern the dynamics of liver regener-
ation and repair will provide unique insights into liver dis-
ease progression, suggest further avenues of research for
targeted therapy for chronic liver diseases, and provide in-




Our computational model extends the model previously
published by Furchtgott, Chow, and Periwal by adding
terms describing the contributions of cell growth and
initially matrix-bound factors to liver regeneration






M 20.8 (rat) Relative nutrient and toxin delivery/absorption
rate in the liver
G 3.5x10−4 (rat) Growth rate of hepatocyte mass [mass
equivalent doublings/min]
kIL6 1.5 Rate at which non-parenchymal cells
(primarily Kupffer cells) are able to modify the
cytokine milieu post-PHx
κIL6 0.9 Rate of cytokine degradation
VJAK 2x10
4 Maximum JAK activation rate
Km
JAK 104 JAK Michaelis concentration
κJAK 0.4 Rate of JAK degradation
[STAT3] 2 Relative concentration of monomeric STAT3
in the liver
VSTAT3 7.5x10
2 Maximum STAT3 phosphorylation rate
Km
STAT3 0.4 pSTAT3 Michaelis concentration
κSTAT3 0.1 Rate of pSTAT3 dephosphorylation
VSOCS3 2.4x10
4 Maximum SOCS3 activation rate
Km
SOCS3 7x10−4 SOCS3 Michaelis concentration
κSOCS3 0.4 Rate of SOCS3 degradation
KI
SOCS3 1.5x10−2 SOCS3 Inhibition effect on STAT3
phosphorylation
VIE 2.5x10
2 Maximum IE gene activation rate
Km
IE 18 IE gene Michaelis concentration
κIE 5 Rate of IE gene degradation
κDEG 7 Rate of ECM degradation by MMPs
κECM 33 Rate of constitutive ECM degradation
kGF 0.113 Rate at which non-parenchymal cells
(primarily hepatic stellate cells) directly &
indirectly produce growth factors post-PHx
κGF 0.23 Rate of growth factor degradation
kup 6x10
−2 Rate of growth factor absorption/binding to
the ECM
kQ 7x10
−3 Maximum rate of hepatocyte transition from
Quiescence to Primed [cells/min]
kP 4.4x10
−3 Maximum rate of hepatocyte transition from
Primed to Replicating [cells/min]
kR 5.4x10
−3 Maximum rate of hepatocyte transition from
Replicating to Quiescence [cells/min]
kprol 2x10
−2 Rate of hepatocyte progression through the
cell cycle [doublings/min]




kap 0.1 Apoptosis rate of damaged hepatocytes
θap 9x10−3 None
βap 4.5x10−3 None
Table 1 Model variables and parameters and their approximate
biological correlates (Continued)
kMBF 1 Rate of release of matrix bound factors
during ECM remodeling
κMBF 1 Degradation rate of matrix bound factors





Q 1 Fraction of hepatocytes in the Quiescent state
P 0 Fraction of hepatocytes in the Primed state
R 0 Fraction of hepatocytes in the Replicating
state
[IL-6] 1 Cytokine microenvironment of the liver
[JAK] 1 Relative levels of activated receptors for
cytokine signals in hepatocytes
[pSTAT3] 1 Relative levels of phosphorylated STAT-3
compared to monomeric STAT-3 or other
downstream effectors of cytokine signaling
(i.e. NF-κB)
[SOCS3] 1 Relative levels of SOCS3 or other inhibitors of
cytokine signaling
[IE] 1 Relative levels of immediate early genes
induced in hepatocytes (e.g. cFOS, cJUN,
and AP-1)
[GF] 1 Relative bioavailability of growth factors
promoting hepatocyte proliferation
[ECM] 1 Relative levels of extracellular matrix buildup
of matrix composed of collagens inhibitory
to regeneration
[MBFECM] 50 Relative levels of matrix bound factors
priming hepatocytes
[MBFFree] 0 Relative levels of free matrix bound factors
that were initially bound by ECM
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following resection [13]. Our computational model con-
sists of 11 ODEs (described in detail in the Methods sec-
tion), 43 parameters (Table 1), and 12 variables
representing molecular levels and cell abundances
(Table 1). The Matlab code used for this study is avail-
able as supplemental information in Additional file 2.
All variables representing molecular levels, except matrix
bound factors (MBF), have an initial steady-state level of
1 and any change thereafter is a fold-change over base-
line. Determination of MBF initial level is described in
the following section. The initial level of quiescent hepa-
tocytes is 1, while initial levels of primed and replicating
hepatocytes are 0. All simulations were performed using
Matlab (Mathworks, Natick, MA).
Extended model predicts the importance of Kupffer
cell-mediated signaling during the priming phase
The importance of direct intercellular signaling leading
to IE gene expression has been widely studied. Direct in-
terventions to intercellular signaling have been shown to
impact liver regeneration dynamics significantly [14].
Whereas, the effects of matrix bound factors (MBF) are
less well appreciated but appear to have a more subtle
effect on regeneration dynamics [15]. Therefore, we rea-
soned that the effects of MBF are likely less than the ef-
fects of IE genes on driving regeneration. We tested
model behavior if the effects of MBFs are just as import-
ant to regeneration as IE gene effects. Rather than match
parameters for MBF signaling to a particular MBF (i.e.
WNT) we tuned the model parameters initial MBF
levels, production rate, and degradation rate such that
the relative magnitude of the priming signal from initially
MBF signaling and IE gene production were of the same
order of magnitude during the timeframes when they were
contributing to hepatocyte priming (Additional file 3:
Figure S2). Table 1 contains the parameters that corres-
pond to this phenotypic behavior. This parameter choice
relies on the assumption that MBF signaling is as import-
ant as IE gene production to induce hepatocyte priming,
and MBFs are depleted following the priming phase. Un-
binding of MBF peaked approximately 45 min post-PHx
and lasted over the duration of the priming phase (6 h
post-PHx), while IE gene levels peaked close to 3 h post-
PHx and remained high throughout the early stages of
liver regeneration (>12 h post-PHx). We found that in-
cluding MBF signaling altered the dynamic mass recovery
only slightly, leading to a sustained offset in mass recovery
compared to the case without MBF signaling (Additional
file 4: Figure S3). The effect of MBF signaling in our
model is slight most likely because the duration of MBF
signaling is shorter than the duration of cytokine signaling.
Because of the negligible effect that MBF signaling had on
liver regeneration dynamics, we excluded its contributions
from the subsequent model analyses.
Extended model with cell growth better accounts for rat
liver regeneration profile
Although the original model proposed by Furchtgott
et al. [13] captured the broad features of liver regener-
ation in rats, it considered relative hepatocyte number as
a measure of tissue response rather than overall mass.
Comparing this simulated number of hepatocytes to ex-
perimental data is difficult because the experimentally
available measurement closest to cell number is relative
tissue mass. When compared to relative tissue mass re-
covery, this model fails to match the mass recovery dy-
namics accurately: specifically, the model without cell
growth fails to capture the experimental observation that
the rat liver doubles in mass by 24 h post hepatectomy
(Fig. 2, “No cell growth” & “Experimental data”) [13, 16].
Our extended model incorporating cell growth could
better account for the dynamic profile of liver mass re-
covery in rats by more accurately simulating mass recov-
ery dynamics (Fig. 2, “Cell growth”). We performed a
log-likelihood ratio test to assess whether our extended
model described the experimental data significantly bet-
ter than the previous model. This test takes into account
the number of parameters used in the model and the
model error in fitting the experimental data. We as-
sumed that the residuals from the fitted models followed
a Gaussian distribution (i.e. there was no non-random
pattern to the residuals) and used one degree of free-
dom, corresponding to the cell growth parameter we
added to the model. For further explanation of the test,
see the Methods section. We found that the original
model had a log-likelihood of 4.42, while our extended
model had a log-likelihood of 9.64. The results of log-
likelihood ratio test showed that our extended model
was able to capture the experimental data more
Fig. 2 Comparison of experimental data of liver regeneration in rats
from Tanoue et al. [16] (Experimental data) to the models proposed
by Furchtgott et al. [13] (No cell growth) and proposed in this work
(Cell growth). The model proposed in this work is able to fully capture
the dynamics of liver repair following 70 % partial hepatectomy in rats
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accurately than the previous model, with a p-value of
0.0012 (G2 = 10.53). The ability to compare our simu-
lated regeneration profiles to experimental mass recov-
ery profiles allowed us to simulate experimentally
observed cases of deficient liver regeneration and predict
molecular and physiological deficiencies underlying
these cases.
Exploring the state space of liver regeneration reveals
distinct regeneration modes
We sampled the model’s parameter space within a range
of biologically reasonable parameter values using a Latin
hypercube sampling method to sample each parameter
uniformly from +/− 50 % of its nominal value. We then
simulated liver regeneration following 70 % PHx using 150
parameter sets and classified the resulting regeneration dy-
namics. We found that liver regeneration is classifiable
into several distinct modes of response to PHx: four regen-
erating modes (Fig. 3a-d): delayed, suppressed, enhanced,
and delayed and enhanced; and two non-regenerating
modes (Fig. 3e,f): unresponsive and liver failure.
Next, we investigated the molecular regulation govern-
ing the distinct regeneration modes (Fig. 4). We found
that for most of the regeneration modes the variability in
molecular regulation was high, often overlapping both the
nominal regeneration case and zero levels (Fig. 4c). These
results show that there is no single molecular profile that
gives rise to a particular regeneration mode and that im-
balances in a combination of factors can have large effects
on regeneration dynamics. Based on these results, we con-
clude that the balance and timing of multiple factors act-
ing in combination is critical in shaping the regeneration
mode following resection. We further investigated specific
molecular imbalances that could lead to instances of each
altered regeneration modes. These investigations can be
found in the supplemental figures (Additional file 5:
Figure S4; Additional file 6: Figure S5; Additional file 7:
Figure S6; Additional file 8: Figure S7; Additional file 9:
Figure S8; Additional file 10: Figure S9).
Sensitivity analysis reveals that molecular and physiological
regulation strongly affects dynamic mass recovery
We performed a local parametric sensitivity analysis to
identify additional factors and network balances signifi-
cantly affecting the liver regeneration dynamics. We
found that the addition of cell growth to the extended
model did not have a strong effect on the maximum
Fig. 3 Model-predicted modes of regeneration revealed through sampling model parameters (+/− 50 % of nominal values). Varying model
parameters simultaneously revealed distinct regeneration modes, including (a) delayed, (b) suppressed, (c) enhanced, (d) delayed and enhanced,
(e) unresponsive, and (f) liver failure. The dashed line is the nominal profile; the gray areas indicate +/− 1 standard deviation
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local sensitivity coefficients of model parameters (Fig. 5a).
The exception to this observation is the maximum sensi-
tivity of the metabolic demand parameter (M), which
changed from positive to negative with the addition of
cell growth. Sensitivity values computed for both the ori-
ginal model and the extended model including cell
growth revealed that both molecular and physiological
parameters showed high sensitivity. The model’s physio-
logical parameters showed the highest absolute sensitiv-
ities, suggesting that such a lumped approach to studying
tissue behavior may exclude detailed predictions about
important biological processes. Model parameters related
to production of factors from non-parenchymal cells as
well as model parameters related to hepatocyte response
to these factors showed high sensitivity, suggesting that
parenchymal and non-parenchymal cell regulation are
both important for governing liver regeneration. Specific-
ally, we identified a potential antagonism between GF
production rate (kGF) and degradation rate (κGF) and be-
tween IL-6 production rate (kIL-6) and IL-6 degradation
rate (κIL-6) (Additional file 11: Figure S10). Increasing the
production rates of IL-6 and GF enhanced overall regener-
ation, while increasing degradation rates inhibited
overall regeneration.
We investigated how the inclusion of cell growth
modified the dynamic sensitivity of the metabolic de-
mand parameter (M). When cell growth is not consid-
ered, increased metabolic demand was inhibitory to liver
recovery during the first 53 h post-PHx, largely due to
increased hepatocyte apoptosis (Fig. 5b). After 53 h, in-
creased metabolic demand enhanced regeneration. With
cell growth considered, the initial inhibitory effect of in-
creasing metabolic demand lasted only for the first 43 h
post-PHx, after which it enhanced mass recovery but to
a lower extent than the model without cell growth
(Fig. 5c). The inclusion of cell growth also allowed us to
recognize a potential dynamic antagonism between
metabolic demand and cell growth rate. Early post-PHx,
hepatocyte growth was a positive contributor to liver re-
generation, while metabolic demand negatively affected
progression of regeneration. At this early time, metabolic
demand acted in hepatocytes predominantly to induce
Fig. 4 Molecular regulation governing altered regeneration profiles. a Average mass recovery, b One representative instance of mass recovery,
c Average molecular regulation for regeneration modes: (1) Delayed, (2) Suppressed, (3) Enhanced, (4) Delayed and Enhanced. Dashed line represents
nominal profile, black line represents average (or [B] one instance of the) profile, gray area represents +/− 1 standard deviation
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apoptosis in damaged cells through high metabolic load,
causing reduced liver mass. After approximately 43 h
post-PHx, high metabolic load induced high response in
non-parenchymal cells causing increased priming and
regeneration. From approximately 43 to 87 h post-PHx,
metabolic load and hepatocyte growth acted synergistic-
ally to promote liver regeneration. Near the termination
stage of liver regeneration, however, hepatocyte growth
inhibited liver regeneration by inducing hepatomegaly
and decreasing the driving force for regeneration.
Paired parameter analysis reveals control principles
governing the network balances driving liver regeneration
We investigated the organizational principles during
liver regeneration by independently varying the pairs of
antagonistic parameters identified from the sensitivity
analysis. We varied each parameter over an order of
magnitude and simulated overall liver mass recovery.
We found that although increasing metabolic demand and
hepatocyte growth rate had opposing effects during the
beginning and end of liver mass recovery, simultaneously
increasing these parameters tended to cause an increase in
overall mass recovery (Fig. 6a). When changed together,
metabolic demand has a much stronger effect on overall
mass recovery than cell growth rate, for metabolic de-
mand parameter values lower than approximately 40 (or
an approximate fold change of 2). When metabolic de-
mand was high (>2 fold change), regeneration is typically
enhanced but certain growth rates coupled with these
high metabolic demands could cause complete liver failure
or govern the magnitude of the enhanced recovery. When
metabolic demand was high (>3 fold change) and growth
rate was low (<0.05, or approximately 200 fold change),
growth rate was not able to compensate for increased
apoptosis caused by high metabolic demand and liver fail-
ure occurred. Based on the results near nominal param-
eter values for metabolic demand and cell growth rate,
metabolic demand leading to cell replication appears to be
a primary driver of liver repair following damage, while
cell growth may be a secondary or compensatory driver.
When we investigated the relationship between IL-6
and GF production and degradation, we found that
Fig. 5 Dynamic local sensitivity analysis of the regeneration model with and without cell growth. a Maximum normalized sensitivities were
calculated for each parameter. b Normalized local sensitivity of metabolic demand when not considering cell growth. Metabolic demand is
inhibitory for the first 53 h post-PHx, likely through increases in cell apoptosis. After 53 h, metabolic demand enhances regeneration, likely
through increased production of growth factors. c Normalized local sensitivities of metabolic load and growth rate reveal a dynamic competition
between replication and growth. From 43–87 h post-PHx growth rate and metabolic demand both drive regeneration. During initiation and
termination, however, imbalances between growth and metabolic load can inhibit regeneration
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relatively slight increases to both IL-6 (Fig. 6b) and GF
(Fig. 6c) production rate increased mass recovery, while
degradation had to increase much more to cause an
equivalent magnitude decrease in mass recovery. This
antagonism was more pronounced in IL-6 balance, but
was relatively subtle in GF balance. For further
visualization of the effects of GF production and degrad-
ation balance, see Additional file 12: Figure S11. These
relationships reveal an organizational principle whereby
production of molecules acts as a means of achieving
coarse-grained control of molecular levels while degrad-
ation acts to achieve fine-tuned control. These results
suggest that non-parenchymal cells may act predomin-
antly as coarse-grained controllers of liver regeneration,
while hepatocyte responsiveness and miRNA or other
regulation may act to achieve fine-tuned control of liver
regeneration.
We further investigated the mechanisms through
which cytokines and growth factors affect regeneration
dynamics. We found that the immediate inflammatory
response to partial hepatectomy, represented in the
model by IL-6 signaling (Fig. 7a), controlled the timing
of the regeneration response (Fig. 7b) by controlling the
magnitude of the priming response (Fig. 7c). In simula-
tions, a slight reduction in IL-6 production rate (causing
an ~25 % decrease in peak IL-6 levels) led to significantly
decreased STAT-3 phosphorylation (~75 % reduced) and a
lower priming response (~10 % reduced) caused by de-
creased IE gene signaling (Fig. 7c). In addition, this de-
crease in IL-6 levels not only lowered the priming
response (Fig. 7c) but also slightly delayed the peak of
priming, from 7 to 8 h post-PHx. This early impaired
priming response propagated through the time course of
regeneration, lengthening the recovery for IL-6 signaling
deficient cases (Fig. 7b). This result indicates that relatively
small upstream events can have a substantial effect on
overall recovery. It is important to consider, however, that
many biological processes (including inflammatory mol-
ecule production and secretion, receptor binding, compe-
tition with anti-inflammatory molecules and signaling
pathways, and cellular responsiveness to inflammation)
contribute to the simulated IL-6 signaling. Deficiencies in
any steps within these processes could lead to the deficient
priming indicated by the model simulation.
Growth factor bioavailability, in contrast, did not affect
the priming phase but became important later in the re-
generation process. Deficiencies in GF production led to
a linearly increasing delay in liver mass recovery (Fig. 8a).
This delay eventually led to a suppression of overall
mass recovery. Low GFs mediated this suppression by
reducing the fraction of hepatocytes in the replicating
phase of the cell cycle (Fig. 8b and c). Unlike inflamma-
tory signaling, however, GF signaling deficiencies did not
change the timing of peak regeneration. In order to shift
the timing of peak regeneration, it was necessary to
lengthen the duration of the cell cycle (Fig. 8d). Decreas-
ing the cell cycle progression rate coupled with a de-
crease in GF bioavailability not only decreased the
magnitude of the cell cycle response, but also delayed
the peak response by desynchronizing hepatocyte entry
into the cell cycle (Fig. 8e).
Translating among species using the computational model
We tested whether translating among species can poten-
tially be achieved simply by adjusting model parameters
in the extended computational model. Prior to simula-
tion, we sought to identify which parameters likely
change among species. The cell cycle duration is known
to be fairly consistent across mammalian species; there-
fore, we maintained this parameter at nominal levels
[17–20]. Similarly, the JAK-STAT pathway is understood
to be ubiquitous in mammalian species. Therefore, we
Fig. 6 Heatmaps show the overall liver mass recovered is sensitive to combinatorial effects of a Metabolic load and hepatocyte growth rate,
b IL-6 turnover rate, and c GF turnover rate. All parameter changes are displayed in Fold change [FC] over nominal parameter value. a The proper
balance between regenerative drive and cell growth in response to stress is required for normal regeneration. b IL-6 and c GF production rates
have large-scale effects on overall recovery, while degradation rates act as fine tuning
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Fig. 8 Effects of decreasing GF bioavailability. a Decreased GF production causes a delay in regeneration. b As GFs become less available, c fewer
hepatocytes enter the cell cycle, decreasing peak of regenerating cells. The synchronicity of hepatocyte entry into the cell cycle, however, is
affected only slightly. d-e To decrease the synchronicity of entry into the cell cycle, it is necessary to decrease the proliferation rate
Fig. 7 Effect of decreasing IL-6 production. a IL-6 signals through the JAK-STAT signaling pathway to prime hepatocytes for replication. b Reduced
IL-6 production causes delayed regeneration, with delays increasing as regeneration progresses. c A slight decrease in IL-6 production (25 % reduction
in peak levels) amplifies as the signal propagates through the JAK-STAT cascade. Ultimately, this slight IL-6 decrease results in reduced STAT-3
phosphorylation (75 % reduction in peak) and reduced priming (~10 % reduction at peak). This reduced priming leads to delayed recovery
and a slightly reduced overall mass recovery (~5 %)
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maintained JAK-STAT signaling pathway parameters
constant across species. Additionally, while the physio-
logical parameters used to approximate multiple path-
ways may indeed change between species, there is little
reason to believe that the essential mechanisms of these
pathways differ any more than the JAK-STAT signaling
pathway does. Therefore we maintained the physio-
logical parameters at nominal levels as well. This as-
sumption of consistent pathway behavior across species
does not take into account any differences in network
dynamics caused by species-specific molecular dynamics,
for example rat IL-6 half-life in rat macrophages com-
pared to human IL-6 half-life in human macrophages.
We considered an approach where all molecular driv-
ing events were maintained constant between species,
leaving the metabolic demand parameter and the cell
growth rate parameter as the only ones available for
modification. It has been shown that metabolic demand
of an organism is proportional to the mass of the organ-
ism raised to an exponential power (estimated to be be-
tween 2/3 and 3/4); this is true for both plants and
animals and appears to be an organizing principle of
biology [21–23]. The metabolic demand parameter is a
lumped parameter approximating extrinsic signals that
occur in parenchymal and non-parenchymal cells and in-
trinsic hepatocyte capacity to respond to these signals;
however, a portion of these signals may be caused by in-
creased nutrient and toxin flux. Therefore, this term rep-
resents, at least in part, a metabolic response to these
fluxes, which may vary among species according to overall
mass. Lumping extrinsic and intrinsic drivers of regener-
ation into one parameter makes it difficult to simulate
experiments where hepatocytes from one species are
transplanted into another, but such a technique is appro-
priate when considering each species individually [24]. In
addition to metabolic demand potentially changing across
species, it is possible that cell growth rate may also differ
across species. We were able to find no studies reporting
grossly observable differences in cell growth rates, while
several studies have suggested that the cell growth rate
across species appeared to be fairly similar among mam-
malian species [25, 26]. These results led us to believe that
cell growth rate likely changes among mammalian species,
but that change is likely not orders of magnitude different.
Therefore, we changed the cell growth rate and metabolic
demand parameters across species in our model to simu-
late regeneration in multiple species.
We fit regeneration profiles of rats, mice, and humans
by simultaneously changing only the hepatocyte growth
rate and metabolic demand parameters and minimizing
the sum of squared error between experimental data and
simulation output. For rats and mice, the growth rates
estimated using this least squares approach were fairly
similar (G = 3.5x10−4 and 9.7x10−4 mass equivalent
doublings/min, respectively). The optimum fit for
humans, however, resulted in a much higher estimated
growth rate (G = 2.5x10−2 mass equivalent doublings/
min). This estimation is inconsistent with literature sug-
gesting cell growth rate is fairly similar among mamma-
lian species [25, 26]. We therefore constrained human
hepatocyte growth rate to the average of rat and mouse
growth rates (G = 6.6x10−4 mass equivalent doublings/
min) (Additional file 13: Table S1) and changed only the
metabolic demand parameter to fit human regeneration
data.
By modifying only hepatocyte growth rate and meta-
bolic demand parameters, and appropriately scaling the
apoptosis parameter θap, we were able to fit regeneration
profiles from rats, mice, and humans post-hepatectomy
(Fig. 9a-c) [16, 27, 28]. We scaled the apoptosis param-
eter θap by multiplying θap by the ratio of Mmouse/human
to Mrat. Both rats and mice regenerate to the initial level
of liver mass within ~168 h post-hepatectomy (7 days),
while humans take nearly 100 days to recover mass fully.
Both rats and mice had a robust response to partial hep-
atectomy, with an early spike in regenerating cells (peak-
ing near 30 h post-PHx). Rats appeared to have a slightly
higher regeneration peak (Fig. 9a), while mice appeared
to sustain regeneration slightly longer than rats (Fig. 9b).
Although these results did not capture the shift in peak
hepatocyte replication from 24 h post-PHx in rats to
48 h post-PHx in mice, fitting the mass recovery dynam-
ics between these two rodent species underscore the
similarity in regeneration response between them.
Humans, on the other hand, showed a lower peak regen-
eration but sustained regeneration across many months
rather than days (Fig. 9c).
After fitting the metabolic demand parameter to ex-
perimental data, we determined an empirical relation-
ship for determining the metabolic demand parameter
from the organism body mass, Equation 1 (Additional
file 14: Figure S12). We used a power-law expression to
describe the relationship between these terms because of
the well-known power-law relationship between organ-
ism mass and metabolic function.
Metabolic Demand ¼ 47:315 Mass−0:1825 ð1Þ
We have shown that it is possible that the difference in
time necessary to regenerate fully is due predominantly to
the differential functional demands of the liver across spe-
cies. Rodents, which live in an environment more prone to
infection and liver injury, may require a higher metabolic
demand (a component of which is the nutrient delivery
per cell) to maintain healthy liver function than humans,
which live in a relatively clean environment. Because blood
flow and overall nutrient delivery does not change follow-
ing PHx, a smaller number of cells are receiving a
Cook et al. BMC Systems Biology  (2015) 9:71 Page 11 of 24
relatively increased nutrient delivery in all species. It is
possible that post-PHx the relative increase in metabolic
demand per cell—and therefore the driving force for
regeneration—may be higher in rodents than in humans.
Liver mass recovery is a much longer process in humans
than in rats, lasting months rather than weeks. While our
assumptions allowed us to model liver regeneration in
humans, other alternative hypotheses about the differ-
ences in liver regeneration between rats and humans re-
main possible. We therefore tested several alternate
hypotheses that may be able to explain the differences in
regeneration profiles between rats and humans. We tested
the hypotheses that humans have an altered stress re-
sponse compared to rats (Hyp 1); that humans have al-
tered matrix remodeling dynamics and ECM-GF binding
compared to rats (Hyp 2); that human hepatocytes have
an altered transition time between physiological states
(Hyp 3); and that human hepatocytes have a longer cell
cycle, a higher apoptosis rate, a higher requiescence rate,
and an altered transition rate between physiological states,
as was assumed by Periwal et al. [29] (Hyp 4). The study
by Periwal et al. [29] reduced the values of parameters
controlling the hepatocyte cell cycle rate, apoptosis rate,
and requiescence rate by a factor of 24, roughly the differ-
ence in lifespan between rats and humans. Additionally,
they used clinical data to fit the three physiological param-
eters governing the rate of hepatocyte transition between
states (kP, kR, and kQ), reasoning that since these parame-
ters abstract multiple signaling pathways and regulation,
these parameters are most likely to be altered between
species. Table 2 contains the parameters used to test these
hypotheses. We compared these hypotheses to our hy-
pothesis that an altered metabolic demand can account
for differences in liver regeneration dynamics between
humans and rats (Hyp 5).
We found that all of the proposed hypotheses were
able to explain human liver regeneration fairly well
(Fig. 10a). The early dynamics of regeneration, however,
were able to differentiate between many of the hypoth-
eses (Fig. 10b,c). At two weeks post-PHx (14 days), the
liver mass recovery should be able to differentiate be-
tween several of the hypotheses (Fig. 10b). The biological
variability in human liver mass recovery, however, may
make this approach challenging. If liver biopsies are
available, the fraction of replicating hepatocytes in these
samples could be used to identify which (if any) of these
Fig. 9 Cross-species comparison of a rat, b mouse, and c human (upper panel) mass recovery profiles with experimental liver regeneration data [16,
27, 28] and (lower Panel) predicted fraction of replicating hepatocytes for each species. This model suggests that the key difference governing
regeneration profiles between species is an altered balance between proliferative and replicative balance in hepatocytes. This species-specific balance
alters the levels of GFs available during regeneration thereby altering the simulated BrdU incorporation of hepatocytes post-PHx. Rats and mice have
similar metabolic loads and growth rates causing similar BrdU incorporation with several slight differences. Rats have a slightly later peak BrdU than
mice (30 h vs. 28 h) and a higher peak value (0.75 vs. 0.66). Mouse BrdU incorporation, however, continues longer than rat. Similarly, humans show a
reduced peak replication response (note change of scale) but a lengthened regeneration period, leading to similar overall recovery
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hypotheses is correct. Because biopsies of regenerating
livers may not be beneficial to regeneration, it may be
more clinically feasible to investigate cytokine and
growth factor levels in the blood, assuming that they
correlate to what is in the liver. Our model predicts that
investigating cytokine levels (Fig. 10d and g), growth fac-
tor levels (Fig. 10e and h), and ECM accumulation
(Fig. 10f and i) at two weeks post-PHx will provide a
surrogate for replication fraction to differentiate between
hypotheses. The hypotheses that cell transition time dif-
fers between species (Hyp 3) and that cell transition
time, replication rate, requiescence rate, and apoptosis
rate differ between species (Hyp 4) gave similar predic-
tions for molecular regulation at 30 days post-PHx;
therefore, to differentiate between these hypotheses, it
may be necessary to also investigate mass recovery or rep-
licating fraction of cells. Furthermore, when measuring
molecular levels in blood of patients, the fold changes
may not match exactly the fold changes predicted to exist
in the tissue from model simulations. What should allow
for differentiation of hypotheses is the patterns of molecu-
lar regulation across multiple proteins.
We varied sets of model parameters to fit simulated
regeneration dynamics to experimental human liver re-
generation data to predict how human liver regeneration
would have to differ from rat liver regeneration for these
hypotheses to hold true. If the human cytokine response
to PHx is entirely responsible for human to rat differences
in regeneration dynamics (Hyp 1), then the production of
pro-inflammatory cytokines should be suppressed in
humans. Similarly, the hepatocyte response to these in-
flammatory cytokines should be suppressed as well. This
would lead to decreased pro-inflammatory cytokine sig-
naling (Fig. 10g – Hyp 1), causing low expression of
MMPs and sustained high levels of ECM (Fig. 10i – Hyp
1). If ECM remodeling and GF signaling is entirely re-
sponsible for human to rat differences (Hyp 2), then GF
production in humans should be slower than rats and hu-
man ECM should be more efficient in binding GF than rat
ECM. This would lead to low levels of GF (Fig. 10h – Hyp
2) and high levels of ECM (Fig. 10i – Hyp 2). If the only
difference between human and rat regeneration is hepato-
cyte transition time between physiological states (Hyp 3),
then the transitions from Q to P and P to R promoting re-
generation should be slower, while the transition from R
to Q should be faster in humans than rats. If the assump-
tions made by Periwal et al. are true (Hyp 4), then the
transition times should respond the same way. These lon-
ger transition times promoting regeneration lead to simi-
lar molecular profiles for these two cases, with high levels
of cytokines and growth factors. Therefore, it becomes ne-
cessary to measure mass recovery to differentiate between
these two hypotheses. The hypothesis that cell show al-
tered transition times (Hyp 3) predicts a higher mass re-
covery at two weeks than the hypothesis proposed by
Periwal et al. (Hyp 4). The difference in mass recovery
at two weeks is caused by the assumption of a slower
cell cycle, requiescence rate, and apoptosis rate by Peri-
wal. et al. (Fig. 10b – Hyp 4). Our hypothesis that lower
metabolic demand is responsible for the differences be-
tween human and rat regeneration (Hyp 5) caused a
lower overall response to PHx in human than in rats,
but one that was sustained over a longer time period.
This would lead to suppressed cytokine and GF signaling
(Fig. 10g and H – Hyp 5) as well as relatively high levels
of ECM (Fig. 10i – Hyp 5), because of low cytokine-
induced MMP production. Patterns of molecular regula-
tion that could differentiate hypotheses are summarized in




Hyp 2:Altered GF storage
and ECM balance
Hyp 3: Altered state
transition rate
Hyp 4: From
Periwal et al. [29]
Hyp 5: Reduced
metabolic demand
kIL6 = 0.1435 κdeg = 4.955 kQP = 1.4x10−3 kQP = 1.1x10−3 M = 20.8217
κIL6 = 0.4942 κECM = 56.30 kPR = 1.5x10−3 kPR = 2.6x10−3 G = 3.474x10−4
VJAK = 1.364x10
3 kGF = 3.288x10
−3 kRQ = 70.9x10
−3 kRQ = 135x10
−3
Km
JAK = 7.565x103 κGF = 2.139x10−3 kreq = 4.17x10−3
κJAK = 0.0398 kup = 0.1008 kap = 4.17x10−3
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Fig. 10 Alternate parameter changes that can reproduce experimental liver regeneration profiles in humans. Parameters were varied to fit
experimental data of human mass recovery to test several possible hypotheses about how human liver regeneration differs from rat: the hypothesis
that humans have a higher stress response than rats (blue, MSE = 6.1x10-3), the hypothesis that humans store a greater quantity of growth factors in
the ECM that is liberated early post-PHx and may have an altered ECM production/degradation balance (red, MSE = 6.25x10-3), the hypothesis that
human hepatocytes have a higher transition time between physiological states (green, MSE = 0.25x10-3), the hypothesis that humans have a longer
cell cycle, a higher apoptosis rate, a higher requiescence rate, and a higher transition rate between physiological states as was assumed by Periwal
et al. [29] (magenta, MSE = 12.16x10-3), and the hypothesis that only the metabolic demand parameter changes (black, MSE = 4.91x10-3). a Simulated
mass recovery compared to experimental data [28]. b Mass recovery over the first 30 days following resection. c Fraction of replicating cells (simulated
BrdU incorporation) post-resection. d IL-6 levels post-resection. e GF levels post-resection. f ECM accumulation post-resection. It may be possible to
differentiate between most of these hypotheses by measuring at 30 days post-resection (g) IL-6, (h) GF, and (i) ECM. To differentiate between the high
transition time hypotheses (green) and the hypothesis presented by Periwal et al. (orange), it may also be necessary to measure mass recovery.
Approximately two weeks post-resection showed the maximum difference between mass recovery between these two hypotheses. MSE =Mean
Squared Error between experimental and simulated data
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Table 3. We recognize, however, that further experimental
results in humans and further model refinement to in-
clude absolute molecular quantification and factors not
included in the current model may be required to differ-
entiate fully between hypotheses.
Predicting effects of chronic disease on liver repair
following partial hepatectomy
Just as non-alcoholic steatohepatitis (NASH), alcoholic
steatohepatitis (ASH), cirrhosis, and diabetes affect liver
function differently, each affects liver repair differently as
well (Fig. 11). Both non-alcoholic and alcoholic steatohe-
patitis suppress liver repair following partial hepatectomy
as early as 48 h post-surgery and lead to a sustained mass
recovery deficit (Fig. 11a,b). Toxin-induced cirrhosis also
suppresses regeneration, causing a sustained offset from
wild-type regeneration (Fig. 11c). The simulated regener-
ation profile for diabetic rats suggests that the disease
enhances early regeneration but delays full recovery
(Fig. 11d). These predictions are consistent with literature
reporting that alloxan-induced diabetic rats show a delay
in regeneration but no suppression of overall recovery
[30]. In humans, studies have shown that diabetes results
in a higher risk of post-operative liver failure and death in
the first 90 days following liver resection, but when
followed for longer than 6 months, diabetes causes no in-
crease in the risk of complication or death, indicating that
diabetes may impact the early stages of regeneration
greater than the later stages [31, 32].
We tested the hypothesis that alterations to non-
parenchymal cell activation are sufficient to explain al-
tered regeneration in these disease phenotypes. We
found that despite the differences in repair dynamics,
each of these regeneration phenotypes could be modeled
by changing a relatively small number of parameters (9
out of 33), including metabolic load, hepatocyte growth
rate, and parameters associated with non-parenchymal
cells (Additional file 15: Table S2). This result indicates
that altered non-parenchymal cell activation is sufficient
to explain altered regeneration in these disease pheno-
types. We investigated how these parameters change be-
tween disease conditions to predict of how diseases could
Table 3 Patterns of molecular regulation (30 days) and mass recovery (14 days) that could differentiate hypotheses of mechanisms
underlying liver regeneration in humans
Hypothesis IL-6 / Inflammation GF ECM Mass Recovery
(1) Altered Inflammation Moderate High High High
(2) Altered ECM remodeling and GF storage High Moderate High Moderate
(3) Altered transition times High High Moderate High
(4) Parameter changes assumed in Periwal et al. [29] High High Moderate Low
(5) Lower metabolic demand Moderate Moderate High Moderate
Fig. 11 Model fit to disease regeneration profiles revealed altered non-parenchymal cell activity coupled with imbalances in the growth/replication
propensity of hepatocytes were sufficient to explain disease-induced inhibition of regeneration. a Non-alcoholic steatohepatitis [16], b Alcoholic
steatohepatitis [41], c Cirrhosis [43], and d Diabetes [44]
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impair regeneration by modulating non-parenchymal cell
activation (Additional file 16: Figure S13; Additional file
17: Figure S14; Additional file 18: Figure S15; Additional
file 19: Figure S16). A summary of our predictions of
disease-impaired regeneration characteristics is available
in Table 4. NASH inhibited regeneration mainly through
impaired priming (Additional file 16: Figure S13). NASH
also caused an inhibited replication response following
PHx, which was likely caused by low priming rather than
GF deficiencies. Impaired priming and reduced replication
caused a majority of mass recovery to occur through cell
growth rather than replication. Although its regeneration
profile is similar to NASH’s, ASH showed a robust prim-
ing response, but it inhibited regeneration mainly through
deficiencies in GF bioavailability and ECM remodeling
(Additional file 17: Figure S14). The slight increase in liver
mass was caused predominantly by cell growth rather
than replication. Toxin-induced cirrhosis caused an en-
hanced priming response in hepatocytes but a reduced
replication response (Additional file 18: Figure S15). Re-
duced GF bioavailability coupled with high levels of ECM
reduced the overall regenerative potential of cirrhotic
livers. In contrast to NASH and ASH, the mass recov-
ery in cirrhosis was mainly due to cell replication rather
than mass increase. Diabetes also inhibited regeneration
through deficiencies in GF signaling (Additional file 19:
Figure S16). These GF deficiencies caused a delay in the
initiation of replication. It is likely that the early enhanced
mass recovery in diabetic rats may be due predominantly
to hepatomegaly, while eventual mass recovery may be
due to replication. Although the exact timing and magni-
tude of deficiencies in inflammation and GF signaling
were not the same for all chronic disease states, all the
chronic diseases simulated here showed deficiencies in
both signaling pathways. This result suggests that many
chronic diseases that affect the liver’s repair ability do so
in a combinatorial manner, altering the dynamics of in-
flammatory response and GF signaling.
Adaptation to chronic diseases also appears to influ-
ence the liver’s ability to recover a normal baseline func-
tion after an acute challenge. At long times post-PHx,
NASH was characterized by sustained high levels of GF
signaling, ASH was characterized by sustained high
levels of IL-6 and reduced ECM accumulation, and dia-
betes was characterized by reduced ECM accumulation
(Additional file 16: Figure S13 Additional file 17: Figure
S14, and Additional file 19: Figure S16). Cirrhosis, on
the other hand, was characterized by all molecular levels
returning to baseline (Additional file 18: Figure S15).
Our prediction of a sustained high inflammatory re-
sponse in ASH simulations is consistent with previous
reports of relatively high levels of inflammatory mole-
cules found in the serum of patients with ASH [33].
This result suggests that one of the fundamental mech-
anisms of disease progression between ASH and NASH
may be a difference in inflammatory response of non-
parenchymal cells.
Although our model simulations showed that altered
non-parenchymal cell behavior is sufficient to cause im-
paired regeneration dynamics that are consistent with
NASH, ASH, diabetes, and cirrhosis, parenchymal cells
likely also contribute to impaired regeneration. We
therefore tested whether alterations in hepatocyte re-
sponse to non-parenchymal cells are sufficient to explain
altered regeneration in these same disease phenotypes
by changing parameters related to hepatocyte response
to non-parenchymal cells (14 out of 33 parameters, Add-
itional file 20: Table S3). We found that for NASH, ASH,
and cirrhosis, alterations in hepatocyte response to non-
parenchymal cells was also sufficient to explain altered re-
generation in these disease phenotypes (Additional file 21:
Figure S17A-C). Altering these hepatocyte response pa-
rameters was insufficient to explain diabetes-impaired re-
generation dynamics (Additional file 21: Figure S17D). In
all cases, the previous set of parameters (Additional file
15: Table S2) gave lower mean squared error (MSE) than
the hepatocyte-specific parameter alterations (Additional
file 20: Table S3). It was interesting to note that the par-
ameter sets used to simulate NASH and ASH eventually
resulted in liver failure, with hepatocyte numbers continu-
ing to decrease as the simulation progressed. The results
of these simulations, together with the simulations altering
non-parenchymal cell behavior and experiments from lit-
erature, suggest that disease conditions likely alter the dy-
namic function of non-parenchymal cells and hepatocytes
during liver regeneration. Therefore when investigating
liver disease states and response to surgical interventions,
a systems-based approach that explicitly accounts for cell-
cell interactions is necessary to account for the underlying
processes fully.
Table 4 Summary of predicted disease effects on liver regeneration
Disease Model Mass Recovery Priming Replication IL-6 Signaling GF ECM
(1) Non-alcoholic Steatohepatitis Suppressed Low Low Low High High
(2) Alcoholic Steatohepatitis Suppressed Sustained Low Sustained Low High
(3) Toxin-induced Cirrhosis Suppressed High Low High Low High
(4) Allotaxin-induced Diabetes Delayed High Delayed & low Sustained Low Low
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Discussion
Our study provides an investigation into the organizational
principles and molecular regulation underlying liver regen-
eration following resection across multiple species and
disease states. Our study identified altered modes of regen-
eration and investigated disease states that cause regener-
ation to follow these altered modes. This study, however,
only addresses surgical resection of the liver and has not
been applied to drug-induced liver injury (DILI). Because
similar archetypal processes also likely govern liver regen-
eration following DILI, it is possible that some of the re-
sults of our modeling study can be generalized to inform
principles underlying regeneration following DILI as well.
The altered regeneration dynamics following DILI indicate
that additional processes need to be added to the model to
accurately capture the complete physiology (for example,
clearance of injured or necrotic hepatocytes and immune
cell infiltration).
This study investigated liver regeneration through a
computational model involving archetypal signaling path-
ways that represent classes of molecular signaling. There-
fore, the simulations in this study suggest relative balances
and timing of molecular signals that may be deregulated
in disease or altered across species. We have used this ap-
proach in a previous study to investigate the molecular
factors governing the altered liver regeneration dynamics
caused by ablation of the gene adiponectin (Adn). Our
modeling approach suggested that the delay and acceler-
ation of regeneration observed in Adn−/− mice was
caused by decreased priming in hepatocytes (seen as de-
creased STAT3 phosphorylation during the first 6 h post-
PHx) and enhanced growth factor signaling (observable by
20–40 h post-PHx) [34]. We then measured STAT3 phos-
phorylation and growth factor levels in liver lysates of
Adn−/− mice and found reduced STAT3 phosphorylation
at 3 and 6 h post-PHx coupled with high levels of ANG-1,
FGF-2, and HGF proteins from 6 to 42 h post-PHx.
Our study suggests several organizational principles of
regeneration. Initiation of regeneration appears to be
governed by the number of hepatocytes entering the
priming phase, which in turn is largely driven by the in-
flammatory response (modeled as IL-6 signaling). The
computational model simulations further suggest that
IL-6 signaling activity is amplified at the level of STAT-3
phosphorylation, so that small changes in inflammatory
response can cause large changes to STAT-3 phosphor-
ylation and significantly alter the regeneration profile.
The timing and magnitude of GF response appears crit-
ical to replication, with low or late GF response sup-
pressing overall regeneration. Our results led us to
predict that chronic diseases impair liver regeneration
through a combination of deficient inflammatory sig-
naling and growth factor bioavailability. We further
predicted that these deficiencies are shared between
non-parenchymal cell activation and hepatocyte re-
sponsiveness to extracellular stimuli.
Our approach allowed us to investigate several hypoth-
eses about how regeneration differs between rats and
humans. By maintaining molecular and phenomeno-
logical parameters constant across species and modifying
metabolic load and hepatocyte growth rate, we were able
to fit experimental regeneration profiles across species.
This approach has the benefit of conserving hepatocyte-
related signaling pathways including the JAK-STAT sig-
naling kinetics across species. These results revealed that
regenerative capacity is likely related to animal mass,
with larger species having fewer energetic resources to
devote to regeneration. This explanation is consistent
with identification of peak regeneration in pigs and dogs
occurring later than in rats and mice (3 days post-PHx
in pigs and dogs, as opposed to 1 day in rodents) [35].
Alternate hypotheses about differences between rat and
human liver regeneration dynamics, however, offer dif-
ferent predictions about dynamic tissue behavior post-
PHx. We predicted that tissue biopsies and scans taken
at two weeks post resection or molecular measurements
at one month post resection in humans could differenti-
ate between these hypotheses.
Another factor governing the length of regeneration
time is how rapidly hepatocytes are able to increase their
functional mass to compensate for lost tissue. Large
mass may not be beneficial to liver repair if much of the
extra mass does not contribute to liver function; there-
fore, the mass regained in this simulation can be seen as
functional mass increase that contributes to liver func-
tion. As opposed to the metabolic demand parameter,
hepatocyte growth rate was not related to animal mass.
Growth rate may therefore be governed by other factors,
such as maximum glucose metabolic flux possible, mito-
chondrial activity and number of mitochondria, and the
relative amount of nutrients available post PHx. By in-
corporating cell growth, the model proposed in this work
was able to capture the rapid increase in tissue mass
humans are capable of, up to 70 % of liver mass restored
by 30 days after 70 % PHx [28]. Experiments measuring
growth rates of hepatocytes in vitro or further hepatec-
tomy experiments performed using pigs or other species
can be used to test and refine the simple relationship pro-
posed between metabolic demand and body mass.
According to our analysis, the number of parameters
that need to be changed to translate across species is rela-
tively small (a minimum of two). Futhermore, the mini-
mum set of parameters changed were physiological
parameters, M and G. This does not mean that there are
no differences in molecular regulation across species; it
does, however, suggest that the differences are the result
of similar processes across species responding to species-
specific physiology. This results in altered molecular and
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regeneration dynamics across species. In contrast, we
changed multiple parameters, including parameters re-
lated to molecular signaling, to simulate disease effect on
liver regeneration. Taken together, these results suggest
that biological processes behaving normally can account
for differences across species but cannot account for dis-
ease effects on regeneration phenotypes.
Although the model describes fairly well experimental
data, the model description of the cell cycle does not
contain specific phases of the cell cycle. The rate of cell
proliferation in the model contains all the steps from
exit from the G0 phase to a complete cell division.
Therefore, this rate also includes any additional time
taken for a quiescent hepatocyte to dedifferentiate, div-
ide, and redifferentiate. Little is known about how long
any dedifferentiation and redifferentiation takes or if the
time needed for these processes varies across species.
Therefore, the overall rate of cell proliferation may vary
between species. Although we did not explicitly address
this possibility in the current study, further studies could
explore this as a potential contribution to the difference in
peak hepatocyte replication times between rats and mice.
Parametric sensitivity analysis of the computational
model revealed that regeneration is dynamically controlled
and that not all factors respond the same across all times.
This result coupled with the pulsatile sensitivity analysis
recently performed on the original model proposed by
Furchtgott et al. [29] indicates that treatments designed to
improve regenerative ability during chronic disease or fol-
lowing liver transplant may need to be dynamic as well
[34]. Extending the results of simulations of chronic
disease states in rats to the human model may assist in
scheduling treatments for patients suffering from
chronic diseases post-transplantation to maximize re-
generation. For example, during the first week (the ap-
parent priming phase in humans) it might be necessary
to renormalize hepatocyte response to inflammation
signals while later treatments (replication phase) may
need to increase growth factor levels.
Our model-based approach offers unique insights into
the mechanisms of liver disease progression in the con-
text of chronic disease; however, there are several limita-
tions inherent to this approach. The first limitation is
that only the JAK-STAT signaling pathway is explicitly
considered in this model. Although this pathway has
been shown to be critical for a normal repair phenotype,
even a hepatocyte-specific STAT-3 knockout does not
completely inhibit regeneration [36]. In this genotype,
signaling through ERK compensates for the lack of
STAT-3. The importance of the liver’s repair mechanism
ensures that multiple compensatory signaling pathways
are available to act [11]. Our model can be extended to
include additional signaling pathways to account for
compensatory signaling and cross-talk. We note, however,
that the present simplification involving cell phenotype
transitions sufficiently captures major features of the liver
regeneration process. Such simplified models have led to
important insights into biological regulation in other con-
texts as well [13, 37, 38].
Another limitation is that the current model takes into
account only linear responses of non-parenchymal cells
during liver repair. Many reviews highlight the import-
ant role of timing of non-parenchymal cell signaling dur-
ing liver repair [10, 11]. For instance, the critical
contribution of non-parenchymal cells has been demon-
strated using animals where Kupffer cells have been
depleted, thereby significantly delaying regeneration fol-
lowing hepatectomy [14]. The current simulations suggest
that Kupffer cells are largely responsible for priming hepa-
tocytes. Hepatic stellate cells appear to be the main
regulator of hepatocyte regeneration, governing both pro-
liferation through control of growth factor bioavailability
and termination of regeneration through ECM production
and degradation. Therefore, moving towards a more com-
prehensive computational model of liver repair in health
and chronic disease requires inclusion of alternative
regulatory mechanisms within hepatocytes, as well as the
activation and signaling of non-parenchymal cells. To fa-
cilitate this integration, one could consider the existing
models of macrophage or Kupffer cell activation and hep-
atic stellate cell activation. For instance, macrophage acti-
vation has been studied using a computational model of
the cytokine-mediated pathways [39, 40]. Specific to the
liver, our group has recently developed a computational
model of cytokine-mediated hepatic stellate cell activation
that incorporates multiple pathways with cross-talk as well
as microRNA mediated regulation [39, 40].
Conclusions
Our computational model was able to match liver regen-
eration profiles across multiple chronic disease models
and across species. This modeling framework can act as
a tool to translate results from rodent experiments to
clinically actionable hypotheses in primates or humans.
Our study suggests that liver regeneration is dynamically
controlled by factors produced by non-parenchymal
cells. Inflammatory signaling (predominantly from Kupf-
fer cells) governs the priming response of hepatocytes,
while growth factors (predominantly produced by hep-
atic stellate cells) govern hepatocyte entry into the cell
cycle. The synchronicity of hepatocyte entry into the cell
cycle is governed by both growth factor levels and tim-
ing as well as proliferation rate of hepatocytes. These
findings underscore the importance of non-parenchymal
cells to recovering the liver’s repair ability from a diseased
state. Therefore, future computational work should expli-
citly take contributions from non-parenchymal cells into
account.
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Methods
Computational model
We used an extended computational model of liver regen-
eration (represented schematically in Fig. 1) to investigate
quantitatively how altering the molecular regulation of he-
patocytes affects the liver’s innate repair ability. A detailed
explanation of initial model derivation and parameter esti-
mation is available in [13]. Our extended model maintains
the framework of the previously published initial model by
allowing hepatocytes to exist in one of three states:
Quiescent (Q), Primed (P), or Replicating (R). Factors
produced by non-parenchymal cells in response to liver
metabolic load (metabolic demand per cell or M/N)













R ¼ kPR GF½ − GF0½ ð ÞP−kRQ ECM½ R
þ kprolR− kapσapR ð4Þ
Where [IE] represents the concentration of immediate
early genes expressed in response to STAT-3 transcrip-
tional regulation and [ECM] represents the amount of
extracellular matrix. σap and σreq are sigmoidal functions
defined as:












The parameters β and θ in each of these equations are
tuned so that when metabolic load is high, σap is high;
conversely, when [GF] is high, σreq is low. Therefore,
when cells are highly stressed (high metabolic load),
apoptosis occurs at a high rate; when GFs are available,
cells remain in the “Replicating” state.
The JAK-STAT signaling pathway, GF production, and
ECM production are modeled as a combination of first
order and Michealis-Menton kinetics, as shown in the
following equations. For a schematic of the JAK-STAT
signaling pathway, see Fig. 3 a.
d
dt
IL6½  ¼ kIL6MN −
V JAK IL6½ 
IL6½  þ kJAKM
−κIL6 IL6½  þ k1 ð7Þ
d
dt
JAK½  ¼ V JAK IL6½ 
IL6½  þ kJAKM
−κJAK JAK½  þ k2 ð8Þ
d
dt
STAT3½  ¼ VST3 JAK½  proSTAT3½ 
2
proSTAT3½ 2 þ kST3M 1þ SOCS3½ =kSOCS3I
 
−
V IE STAT3½ 
STAT3½  þ kIEM
−
VSOCS3 STAT3½ 
STAT3½  þ kSOCS3M




SOCS3½  ¼ VSOCS3 STAT3½ 






IE½  ¼ V IE STAT3½ 
STAT3½  þ kIEM
−κIE IE½  þ k5 ð11Þ
d
dt




ECM½  ¼ −kdeg IL6½  ECM½ −κECM ECM½ 
þ k6 ð13Þ
Where [proSTAT3] represents the concentration of
monomeric STAT-3 available to dimerize following IL-6
signaling. It should be noted that in the original model
our [IL-6] term representing cytokine signaling was
called [TNF]. Cannonically, TNF signals through the
NF-κB cascade, while IL-6 signals through the JAK-
STAT cascade. Table 1 states that the approximate bio-
logical correlate of the [IL-6] variable in the model is the
“Cytokine microenvironment of the liver”. As previously
described in [13] and in [34], the [IL-6] variable should be
considered a lumped variable representing the physio-
logical impact of general cytokine signaling rather than an
exact analogue to IL-6 protein levels. Therefore, we used
the name [IL-6] for this variable with parameters derived
from TNF.
The overall cell mass, N, was modified from the initial
model to include cell growth of primed and replicating
cells in response to metabolic load as follows:
N ¼ Qþ G P þ Rð Þ ð14Þ
Where G represents the relative cell mass, which is
initially set to 1.
Additionally, when considering the contribution of
matrix bound factors to the priming phase of
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¼ −kMBF 1ECM½ − ECM½ 0
 
þ kup GF½  ECM½  ð15Þ
Where MBFECM represents the matrix-bound signals,
which are released from the matrix when matrix is de-
graded at a rate of kMBF. We assumed that these signal-
ing factors, which could contain growth factors such as
HGF and FGF, were replenished at a rate equivalent to
growth factor uptake by the ECM.
dMBFFree
dt
¼ kMBF 1ECM½ − ECM½ 0
 
− κMBF MBFFree½ 
ð16Þ
Where MBFFree represents the signaling factors re-
leased from matrix and κMBF is the degradation rate of
MBFFree once they have been released.
These additional signals (specifically, MBFFree) act to
prime hepatocytes. We assumed that the transition rate
from quiescent to primed was similar no matter whether
MBF or IE gene signals were driving the transition. We
therefore modified equations 2 and 3 as follows to take
this additional signaling into account.
d
dt
Q ¼ −kQP IE½ − IE0½ ð ÞQ−kQP SFree½ Q
þ kRQ ECM½ Rþ kreqσreqP−kapσapQ ð2aÞ
d
dt
P ¼ kQP IE½ − IE0½ ð ÞQþ kQP SFree½ Q
− kPR GF½ − GF0½ ð ÞP − kreqσreqP−kapσapQ
ð3aÞ
All simulations were performed in Matlab (Math-
works, Natick, MA). Model equations were set up to
prevent molecular levels from becoming negative; how-
ever, some parameter sets combined with the integration
tolerances of ode15s led to GF levels becoming negative
at longer simulation times (greater than 150 h). These
impossible GF levels did not significantly impact the re-
generation profile because most of the growth had con-
cluded by the time GF became negative. Because of
these numerical instabilities, however, GF levels were
constrained to a minimum of 1.
Transforming published data on liver regeneration into
fractional recovery of tissue mass
High fructose-induced steatosis (NASH) and Controls
In the study by Tanoue et al. [16], male Sprague–Dawley
rats (8 weeks old) were fed either a high fructose diet
(total calories from 66 % fructose, 11 % fat, and 19 %
protein) or a control diet (chow with total calories from
10 % fructose, 12 % fat, and 19 % protein) for a period of
four weeks. Rats with high fructose-induced non-
alcoholic steatohepatitis (NASH) showed high serum tri-
glycerides, accumulation of hepatic fat, and more severe
insulin resistance, indicating a disease state similar to
human NASH. Following four weeks of their respective
diets, rats were anesthetized with ether and a 70 % par-
tial hepatectomy was performed. Following resection,
rats were fed a standard CE-2 diet. During recovery from
resection, rats were sacrificed and their regenerating
livers were removed and weighed. The data reported in
this study were given in “liver regeneration rate”, which
is the percentage of liver mass recovered as normalized
to the initial remnant liver mass immediately following
hepatectomy, according to equation 17 [16].
Liver Regeneration Rate




Liver regeneration rate is the fractional mass recovery
minus the remnant liver fractions; therefore, we added
30 % to the reported liver regeneration rate to convert
liver regeneration rate to fractional mass recovery.
Ethanol-induced steatosis (ASH)
In the study by Yang et al. [41], Sprague–Dawley rats
(125 g body weight) were fed either a liquid ethanol diet
(355 kcal ethanol, 115 kcal carbohydrates, 360 kcal fat,
and 180 kcal protein per liter) or a control diet (470 kcal
carbohydrates, 360 kcal fat, and 180 kcal protein per
liter) for a period of five weeks. After five week adapta-
tion to these diets, rats were anesthetized using ether
and a 70 % PHx was performed. Rats were sacrificed at
24 h and 48 h post-PHx, and liver weight was measured.
The data presented by Yang et al. [41] were given in per-
centage of initial weight at 24 and 48 h post-hepatectomy
[41]. We assumed that the initial % of initial liver weight
was 30 % because a 70 % PHx was performed. Therefore,
to convert from % initial liver weight to fractional recov-
ery, we divided % initial liver weight by 100 %. Although
we imposed no further constraints on regeneration in rats
with ASH, based on observations of 3H-thymadine in-
corporation from previous studies, we surmise that it is
unlikely that significant hepatocyte replication occurs be-
yond 48 h post-hepatectomy in alcohol-fed rats [42].
Toxin-induced cirrhosis
In the study by Kaibori et al. [43], 6 week old male Spra-
gue Dawley rats (150-200 g body weight) were injected
with thioacetamide (4 % thioacetamide at 20 mg/100 g
body weight) thrice weekly for 10 weeks. The rats were
then kept for an additional 3 weeks to allow for
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thioacetamide washout. Cirrhosis was then confirmed by
histology. Following development of cirrhosis, rats were
anesthetized with ether and 45 % partial hepatectomy was
performed. Rats were sacrificed and their livers were ex-
cised and weighed at 1, 2, 3, 5, and 7 days post-PHx [43].
At the time of PHx, remnant cirrhotic livers from 10
additional rats were weighed as a measure of original
remnant liver weight. Liver regeneration rate was calcu-
lated as follows:





Therefore, the only conversion necessary to convert
liver regeneration rate to fractional mass recovery was to
divide by 100 %.
Toxin-induced type 1 diabetes
In the study by Johnston et al. [44], diabetes was induced
in male Wistar rats (200-300 g body weight) by adminis-
tering a single dose of streptozotocin (65 mg/kg body
weight) injected into the tail vein under light anesthesia
(ether). Rats then received 0.28 M glucose to drink. Partial
hepatectomy was performed five days following streptozo-
tocin administration. During recovery, rats were sacrificed
and dry liver weight was measured at 12, 24, and 48 h
post-resection. The data reported in this study were given
in liver dry weight percent of total body weight.
To convert these data to fractional recovery, we first cal-
culated the baseline liver dry weight to total body weight
percent. From the 10 week-old organ weights of the
Phenome project at the National BioResource Project for
the Rat in Japan (www.anim.med.kyoto-u.ac.jp/nbr), we
found that the average liver to body weight percent across
rat strains (and specifically for the WST.F334-Kmch/Kyo
strain) is approximately 3 %. Johnston et al. [44] states that
water content in the livers of sham-operated rats was
64.9 %. Thus, the following two equations were constructed
to solve for initial dry liver to body weight percent.





25.1% ¼ Water 64.9
%
 ð20Þ
where Dry Liver and Water are the weights of the dry
tissue and water content of the tissue. Equation 20, can
be rearranged as follows.
Water ¼ 2:586 Liverð Þ ð21Þ
Thus, equation 19 can be solved for baseline dry liver
to body weight percentage by inserting equation 21 into
equation 19 to yield baseline dry liver to body weight
percentage was 1.16 % in the rats used in this study. A
70 % PHx yields a starting dry liver to body weight per-
centage of 0.348 % corresponding to a fractional recov-
ery of 0.3. All data in this study were therefore scaled by
a factor of 0.3/0.348 % to convert the dry liver to body
weight percentage to fractional recovery [44].
Previous studies have suggested that alloxan-induced
diabetic rats showed a delay in regeneration but that dia-
betes did not suppress overall recovery [30]. We there-
fore constrained recovery at 300 h post-PHx in diabetic
rats to be the same as for wild-type rats.
Mouse liver regeneration
Male mice aged 8–12 weeks (129S1) were fed standard
mouse chow ad libitum. Mice were anesthetized by
pentobarbital and 70 % PHx was performed. The data
from Shu et al. [27] for control mice were given in liver
to body weight ratio. To convert these data to fractional
recovery, these data were scaled by 0.3 divided by initial
value for liver-to-body weight ratio.
Human liver regeneration
The data presented by Periwal et al. [29] were already
given as the fraction of original liver volume, hence re-
quiring no conversion. Similarly, the data presented by
Pomfret et al. [28] were given in percent regeneration,
which is defined as remnant volume divided by original
volume (x100 %). No conversion was required for these
data as well.
Sensitivity analysis
Normalized sensitivity coefficients were estimated by
changing each parameter (pi) by +/− 10 % of its nominal
value and calculating sensitivity at each simulation time
point according to equation 22.
Si tð Þ ¼ ΔMass tð Þ=Mass tð ÞΔpi=pi
ð22Þ
Mass(t) represents the nominal mass fraction of hepa-
tocytes at any given time, t, and ΔMass(t) is the devi-
ation from nominal caused by the parameter change.
The result is a dynamic parametric sensitivity, showing
how the profile of liver regeneration responds to changes
in parameters as a function of time.
Statistical methods
We performed a log-likelihood ratio test to assess
whether our extended model described the experimental
data significantly better than the previous model. This
test takes into account the number of parameters used
in the model and the model error in fitting the experi-
mental data. We assumed that the residuals from the
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fitted models followed a Gaussian distribution (i.e. there
was no non-random pattern to the residuals) and used
one degree of freedom, corresponding to the cell growth
parameter we added to the model. In the case of this
model comparison, the original model has 1 fewer pa-
rameters than the extended model, we therefore consid-
ered the extended model as the unrestricted model. For
each model, the log-likelihood function was used to cal-
culate the model fit to experimental data from Tanoue
et al. [16] in accordance with equation 23.
l μ; σ2; x1; x2; … ; xn
  ¼ − n
2











Where μ and σ2 were estimated from the residuals for
each model.
The ltestratio function in Matlab was used to compare
the likelihood of the two models.
Availability of supporting data
No datasets were generated in this study. The model
used in this study is available as a supplemental file.
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